Biomaterials Market

Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural) & By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) - Global Forecast to 2024

Report Code: BT 1556 Jun, 2019, by marketsandmarkets.com

[238 Pages Report] The biomaterials market is projected to reach USD 207 billion by 2024 from USD 105 billion in 2019, at a CAGR of 14.5% between 2019 and 2024. Factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases are driving the growth of the market. Emerging markets such as China, India, and Japan are the key areas of opportunity for players in this market. However, stringent clinical & regulatory processes and unfavorable healthcare reforms in the US are expected to restrain the growth of this market during the forecast period.

Biomaterials Market

To get more details on this report, Download PDF Brochure

Market Dynamics

Increased funds and grants by government bodies and universities for the development of novel biomaterials

The demand for and usage of biomaterials in various medical applications has increased significantly across the globe over the last few years. Also, several government bodies and universities have extended their help in the form of investments, funds, and grants to promote research into the development of novel biomaterials. Mentioned below are some of the important developments in this regard:

  • Two European Commission programs allocated USD 15.6 billion for biomaterials research for a period of five years (2013–2017).
  • In March 2018, Drexel University granted USD 200,000 to the National Science Foundation for research on how biomaterial-mediated control over macrophage behavior affects biomaterial vascularization.
  • In October 2016, researchers from the University of Strathclyde received a grant of USD 106,729 (EUR 98,848) from the Engineering and Physical Sciences Research Council (EPSRC) for engineering self-assembling silk hydrogels for the delivery of stem cells.
  • In January 2016, researchers from the University of Bolton received a grant of USD 107,805 (EUR 99,845) from EPSRC for the development of multifunctional gel scaffolds for cell delivery and tissue repair.
  • In October 2015, the Department of Defense (DoD) awarded USD 6 million to the Houston Methodist Research Institute (US) for studying two new materials that would help repair complex fractures in long bones.
  • In August 2015, the EPSRC granted USD 6.04 million (GBP 5.4 million) to Morgan Alexander (professor at the University of Nottingham) to support the Next Generation Biomaterials Discovery program.

Such research and funding activities are expected to boost the development of innovative biomaterials, thus offering an array of opportunities for the growth of the biomaterials market.

Stringent clinical & regulatory processes

Biomaterial-based medical devices are stringently regulated in several regions, including North America, Europe, and Asia, to ensure their quality and efficacy. This is primarily attributed to the fact that most biomaterial-based medical devices are implantable. All new biomaterials require proof that they are safe and effective before they can be approved for marketing. In the US, the process for approval follows strict guidelines and regulations set by the FDA. According to the FDA, biomaterial-based products such as implantable pacemakers, stents, and heart valves are classified as Class III devices, which pose the highest potential risk of illness or injury. Thus, these devices are subjected to the premarket approval application pathway (which is the most stringent type of device marketing application).

The development of biomaterials involves time-consuming processes and expensive clinical trials. As these products have to be implanted inside the human body, they need to be biocompatible and have to undergo the ISO biocompatibility testing standards. However, it is difficult to anticipate the biocompatibility until the later stages of clinical trials, making companies and investors apprehensive of investing in this market. In addition, regulatory procedures are complicated, restrictive, and depend on biomaterial composition and future application. These factors are expected to restrain market growth to a certain extent in the coming years.

Increasing number of free-trade agreements

Free-trade agreements (FTAs) comprise a treaty between two or more countries, aimed at reducing trade barriers such as tariffs and customs. These agreements are aimed at enabling rapid and smoother movement of goods across the member countries, improve market access, and enhance the economic relationship between the member countries. FTAs also enable the elimination of duties on trade goods, including pharmaceuticals and medical devices. As a result, FTAs offer major opportunities for medical device companies to increase their exports and expand their market reach in member countries. The recent implementations of several FTAs are thus expected to increase the demand for medical devices across the participating countries. A few of the agreements are listed below.

Shortage of skilled surgeons

According to the Lancet Commission on Global Surgery, ~2.2 million more surgeons, anesthetists, and obstetricians are required in low- and middle-income countries (LMICs) each year. Also, major healthcare markets such as the US, Germany, and the UK are witnessing a dearth of surgeons in their respective healthcare systems. For instance, according to the Association of American Medical Colleges, a deficit of 41,000 general surgeons is estimated in the US by 2025. Similarly, Ohio State University has projected that there would be about 3,000 cardiothoracic surgeons available to cover about 854,000 cases by 2030. Similarly, in the UK, there is 1 vascular surgeon per 137,000 individuals (Source: Survey conducted by the Vascular Society of Great Britain & Ireland in 2016).

The significant shortage of surgeons available to handle the increasing demand for procedures is expected to affect the uptake of implantable devices in the coming years. This is considered as a major challenge for the growth of the biomaterials market.

The metallic biomaterials dominated the biomaterials market in 2018

By type, the market is segmented into metallic, polymeric, ceramic, and natural biomaterials. The metallic biomaterials segment dominated the market in 2018. The dominant share of this segment is primarily attributed to the wide use of metals in the manufacturing of medical devices used in cardiovascular, dental, and orthopedic applications. However, the polymeric biomaterials segment is expected to grow at the highest CAGR during the forecast period. This is mainly due to the increasing use of polymers in soft-tissue applications such as plastic surgeries.

Biomaterials Market

To get more details on this report, Request FREE Sample

The APAC market is expected to grow at the highest CAGR during the forecast period

North America dominated the market in 2018. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period. Japan’s growing healthcare industry, rising geriatric population in China and India, and rising prevalence of cardiovascular diseases in India are some of the key factors driving the growth of the market in the Asia Pacific region.

Key Market Players

Prominent players in the market are Royal DSM (Netherlands), BASF SE (Germany), Corbion (Netherlands), Carpenter Technology Corporation (US), Evonik Industries (Germany), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), Celanese Corporation (US), CoorsTek Inc. (US), CeramTec (Germany), and GELITA AG (Germany).

Royal DSM offers coatings, drug delivery platforms, and a wide range of biomedical materials, such as bioceramics, biomedical polyethylenes, biomedical polyurethanes, collagens, and ophthalmic biomaterials for various applications, such as orthopedics, sports medicine, ophthalmology, general surgery, and cardiology. The company offers polyethylenes under the brand names—Dyneema Purity Woven, Dyneema Purity Black Fiber, Dyneema Purity Radiopaque Fiber, Dyneema Purity SGX Fiber, Dyneema Purity TG Fiber, Dyneema Purity UG / VG Fiber, and Dyneema Purity Membrane.

Scope of the Report:

Report Metric

Details

Market size available for years

2017–2024

Base year considered

2018

Forecast period

2019–2024

Forecast units

Value (USD)

Segments covered

Type, Application, and Region

Geographies covered

North America, Europe, the Asia Pacific, and the Rest of the World

Companies covered

Royal DSM (Netherlands), BASF SE (Germany), Corbion (Netherlands), Carpenter Technology Corporation (US), Evonik Industries (Germany), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), Celanese Corporation (US), CoorsTek Inc. (US), CeramTec (Germany), and GELITA AG (Germany).

The research report categorizes the market into the following segments and subsegments:

Biomaterials Market, by Type

  • Metallic Biomaterials
  • Ceramic Biomaterials
  • Polymeric Biomaterials
  • Natural Biomaterials

Biomaterials Market, by Applications

  • Cardiovascular
  • Orthopedic
  • Ophthalmology
  • Dental
  • Plastic Surgery
  • Wound Healing
  • Tissue Engineering
  • Neurology
  • Other Applications

Biomaterials Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World

Recent Developments

  • In July 2019, Royal DSM (Netherlands) entered into a partnership with ProMed Pharma (US). This partnership was aimed at developing novel sustained release drug delivery solutions in the polymeric drug delivery area.
  • In 2017, Royal DSM (Netherlands) launched Dyneema Purity Black Fiber.

Critical questions answered in the report:

  • How will the current technological trends affect the market in the long-term?
  • What are the reasons contributing to the growth of the polymeric market?
  • Which regions are likely to grow at the highest CAGR?
  • What are the challenges hindering the adoption of biomaterials?
  • What are the growth strategies being implemented by major market players?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 22)
    1.1 Objectives of Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Research Methodology (Page No. - 26)
    2.1 Research Methodology Steps
    2.2 Research Design
    2.3 Secondary Data
           2.3.1 Primary Data
                    2.3.1.1 Key Data From Primary Sources
                    2.3.1.2 Key Industry Insights
    2.4 Market Size Estimation Methodology
    2.5 Market Data Validation and Triangulation
    2.6 Assumptions for the Study:

3 Executive Summary (Page No. - 35)

4 Premium Insights (Page No. - 41)
    4.1 Market Overview
    4.2 Market, By Type, 2018 (USD Billion)
    4.3 Market: Geographic Snapshot

5 Market Overview (Page No. - 44)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increased Funds and Grants By Government Bodies and Universities for the Development of Novel Biomaterials
                    5.2.1.2 Increasing Demand for Implantable Devices
                    5.2.1.3 Growing Demand for Biomaterials in Plastic Surgery and Wound Healing Applications
                    5.2.1.4 Rising Incidence of Cardiovascular Diseases
                    5.2.1.5 Increasing Research on Regenerative Medicine
           5.2.2 Restraints
                    5.2.2.1 Stringent Clinical & Regulatory Processes
                    5.2.2.2 Unfavorable Healthcare Reforms in the US
           5.2.3 Opportunities
                    5.2.3.1 Growing Healthcare Market in Emerging Economies
                    5.2.3.2 Increasing Number of Free-Trade Agreements
           5.2.4 Challenges
                    5.2.4.1 Limitations of Biomaterial-Based Products
                    5.2.4.2 Shortage of Skilled Surgeons

6 Regulatory Assessment (Page No. - 51)
    6.1 Introduction
    6.2 US
           6.2.1 Introduction
           6.2.2 Fda Device Classification
           6.2.3 US: Regulatory Approval Timeline Assessment
           6.2.4 Stringent Fda Regulations Governing Product Approvals
    6.3 Canada
           6.3.1 Introduction
           6.3.2 Canada: Regulatory Approval Timeline Assessment
           6.3.3 Health Canada Classification
    6.4 Europe
           6.4.1 Introduction
           6.4.2 European Medical Device Classification
           6.4.3 Europe: Regulatory Approval Timeline Assessment
           6.4.4 European Regulatory Process to Get More Stringent in Future
    6.5 Japan
           6.5.1 Introduction
           6.5.2 Pmda Device Classification
           6.5.3 Japan: Regulatory Approval Timeline Assessment
           6.5.4 Revision of the Pharmaceutical Affairs Law (PAL) and Implementation of the New Pmd Act in Japan
    6.6 China
           6.6.1 Introduction
           6.6.2 Cfda Device Classification
           6.6.3 China: Regulatory Approval Timeline Assessment
           6.6.4 Rising Hurdles in the Regulatory Process in China
    6.7 India
           6.7.1 Introduction
           6.7.2 Indian Medical Devices Classification
    6.8 Australia
           6.8.1 Introduction
           6.8.2 Tga Device Classification
           6.8.3 Australia: Regulatory Approval Timeline Assessment

7 Biomaterials Market, By Type (Page No. - 73)
    7.1 Introduction
    7.2 Metallic Biomaterials
           7.2.1 Stainless Steel
                    7.2.1.1 Stainless Steel Dominates the Metallic Market
           7.2.2 Titanium & Titanium Alloys
                    7.2.2.1 Rising Number of Joint Replacement Procedures Will Drive the Market for Titanium Biomaterials
           7.2.3 Cobalt-Chrome Alloys
                    7.2.3.1 Low Cost and Excellent Corrosion Resistance have Driven the Use of Cobalt-Chrome Alloys
           7.2.4 Gold
                    7.2.4.1 Expanding Applications of Gold Nanoparticles to Drive the Demand for Gold Biomaterials
           7.2.5 Silver
                    7.2.5.1 Toxic Properties and Low Aesthetic Appeal Likely to Limit the Use of Silver in Biomaterial-Based Products
           7.2.6 Magnesium
                    7.2.6.1 Biodegradable Characteristic of Magnesium have Stimulated the Growth of This Market Segment
    7.3 Polymeric Biomaterials
           7.3.1 Polymethylmethacrylate
                    7.3.1.1 Pmma Dominates the Polymeric Market
           7.3.2 Polyethylene
                    7.3.2.1 Wear and Tear Resistance of Polyethylene have Made It Popular in Hip and Knee Joint Replacements
           7.3.3 Polyester
                    7.3.3.1 Biodegradable Nature and Biocompatibility of Polyester Will Drive Its Use in Various Medical Applications
           7.3.4 Polyvinylchloride
                    7.3.4.1 Heavy Chlorine Content of Pvc is Likely to Hamper the Market Growth
           7.3.5 Silicone Rubber
                    7.3.5.1 Silicone Rubbers are Non-Reactive, Stable, and Resistant to Extreme Environments and Temperatures
           7.3.6 Nylon
                    7.3.6.1 Nylon’s Low Weight, Corrosion Resistance, and Wide Applications are Expected to Drive Market Demand
           7.3.7 Polyetheretherketone
                    7.3.7.1 Peek is Gaining Popularity as A Viable Alternative to Metals
           7.3.8 Other Polymeric Biomaterials
    7.4 Ceramics
           7.4.1 Calcium Phosphate
                    7.4.1.1 Calcium Phosphate Drives Ceramic Biomaterial Market Segment
           7.4.2 Zirconia
                    7.4.2.1 Bio-Inertness and Low Wear Rate of Zirconia Will Boost the Market Growth
           7.4.3 Aluminum Oxide
                    7.4.3.1 Increasing Use of Aluminum Oxide in Hip Replacements and Dental Implants to Drive the Market
           7.4.4 Calcium Sulfate
                    7.4.4.1 Fast Resorption Rate of Calcium Sulfate is Likely to Hamper Its Use
           7.4.5 Carbon
                    7.4.5.1 Increasing Use of Carbon Nanofibers in Regenerative Medicine and Cancer Treatment Will Drive Market Growth
           7.4.6 Glass
                    7.4.6.1 Rising Number of Orthopedics and Dental Procedures Likely to Drive the Demand for Glass Biomaterials
    7.5 Natural Biomaterials
           7.5.1 Hyaluronic Acid
                    7.5.1.1 Rising Prevalence of Osteoarthritis to Drive Hyaluronic Acid Market
           7.5.2 Collagen
                    7.5.2.1 Rising Prevalence of Target Applications to Drive Growth in Collagen Market
           7.5.3 Gelatin
                    7.5.3.1 Low Cost of Gelatin to Drive Its Market Growth
           7.5.4 Fibrin
                    7.5.4.1 Fibrin Biomaterials Were Among the First Used to Prevent Bleeding
           7.5.5 Cellulose
                    7.5.5.1 Cellulose Find Applications in Wound Healing, Skin Regeneration, and Ophthalmology
           7.5.6 Chitin
                    7.5.6.1 Chitin Accelerates Skin Regeneration and Possesses High Biocompatibility
           7.5.7 Alginates
                    7.5.7.1 Various Applications of Alginates Include Wound Healing, Tissue Engineering & Regenerative Medicine, and Drug Delivery
           7.5.8 Silk
                    7.5.8.1 The Flexibility, Glossiness, and Adhesive Abilities of Silk have Made It Popular in Cosmetic Applications

8 Biomaterials Market, By Application (Page No. - 103)
    8.1 Introduction
    8.2 Cardiovascular
           8.2.1 Catheters
           8.2.2 Stents
           8.2.3 Implantable Cardiac Defibrillators
           8.2.4 Pacemakers
           8.2.5 Sensors
           8.2.6 Heart Valves
           8.2.7 Vascular Grafts
           8.2.8 Guidewires
           8.2.9 Others
    8.3 Orthopedic
           8.3.1 Joint Replacement
                    8.3.1.1 Knee Replacement
                    8.3.1.2 Hip Replacement
                    8.3.1.3 Shoulder Replacement
                    8.3.1.4 Others
           8.3.2 Viscosupplementation
           8.3.3 Bioresorbable Tissue Fixation
                    8.3.3.1 Suture Anchors
                    8.3.3.2 Interference Screws
                    8.3.3.3 Meniscal Repair Tacks
                    8.3.3.4 Meshes
           8.3.4 Spine
                    8.3.4.1 Spinal Fusion Surgeries
                    8.3.4.2 Minimally Invasive Fusion Surgeries
                    8.3.4.3 Motion Preservation & Dynamic Stabilization Surgeries
                               8.3.4.3.1 Pedicle-Based Rod Systems
                               8.3.4.3.2 Interspinous Spacers
                               8.3.4.3.3 Artificial Discs
           8.3.5 Fracture Fixation Devices
                    8.3.5.1 Bone Plates
                    8.3.5.2 Screws
                    8.3.5.3 Pins
                    8.3.5.4 Rods
                    8.3.5.5 Wires
           8.3.6 Synthetics Bone Grafts
    8.4 Ophthalmology
           8.4.1 Increasing Prevalence of Eye Diseases to Drive Market Growth
           8.4.2 Contact Lenses
           8.4.3 Intraocular Lenses
           8.4.4 Functional Replacement of Ocular Tissues
           8.4.5 Synthetic Corneas
           8.4.6 Others
    8.5 Dental
           8.5.1 Synthetic Dental Biomaterials Include Metals, Ceramics, Polymers, and Composite Structures
           8.5.2 Dental Implants
           8.5.3 Dental Bone Grafts & Substitutes
           8.5.4 Dental Membranes
           8.5.5 Tissue Regeneration
    8.6 Plastic Surgery
           8.6.1 Growing Number of Cosmetic Surgeries Performed to Drive the Market for Biomaterials
           8.6.2 Soft-Tissue Fillers
           8.6.3 Craniofacial Surgery
    8.7 Wound Healing
           8.7.1 Biomaterials are Extensively Used in Various Wound Healing Products
           8.7.2 Wound Closure Devices
                    8.7.2.1 Sutures
                    8.7.2.2 Staples
           8.7.3 Surgical Hemostats
           8.7.4 Internal Tissue Sealants
           8.7.5 Adhesion Barriers
           8.7.6 Hernia Meshes
    8.8 Tissue Engineering
           8.8.1 Increasing Demand for Enhanced Mechanical Performance of Tissue-Engineered Implants to Support the Growth of This Application Segment
           8.8.2 Scaffolds for Regenerative Medicine
           8.8.3 Nanomaterials for Biosensing
           8.8.4 Tailoring of Inorganic Nanoparticles
    8.9 Neurological/Central Nervous System Applications
           8.9.1 The Major Application Areas of Biomaterials in Cns Disorders Include Shunting, Cortical Neural Prosthesis, and Neural Stem Cell Encapsulation
           8.9.2 Shunting Systems
           8.9.3 Cortical Neural Prosthetics
           8.9.4 Hydrogel Scaffolds for Cns Repair
           8.9.5 Neural Stem Cell Encapsulation
    8.10 Other Applications
           8.10.1 Drug Delivery Systems
           8.10.2 Gastrointestinal Applications
           8.10.3 Bariatric Surgery
           8.10.4 Urinary Applications

9 Biomaterials Market, By Region (Page No. - 166)
    9.1 Introduction
    9.2 North America
           9.2.1 US
                    9.2.1.1 US Dominates the North American Market
           9.2.2 Canada
                    9.2.2.1 Increasing Incidence of Cardiovascular Diseases to Drive Market Growth in Canada
    9.3 Europe
           9.3.1 Germany
                    9.3.1.1 Large Medical Devices Market to Support the Adoption of Biomaterials in Germany
           9.3.2 UK
                    9.3.2.1 Availability of Funds and Rising Cardiovascular Procedures to Drive the Market in the UK
           9.3.3 France
                    9.3.3.1 Rising Aging Population and Associated Diseases to Drive the Market in France
           9.3.4 Spain
                    9.3.4.1 Increasing Research Activities on Biomaterials to Drive the Growth in Spain
           9.3.5 Rest of Europe (RoE)
    9.4 Asia Pacific
           9.4.1 Japan
                    9.4.1.1 Growing Medical Devices Industry to Drive Market Growth
           9.4.2 China
                    9.4.2.1 Lucrative Medical Devices Industry in China
           9.4.3 India
                    9.4.3.1 Large Population Base and Growing Medical Tourism in India to Drive the Growth of Biomaterials
           9.4.4 Rest of Asia Pacific (RoAPAC)
    9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. - 196)
     10.1 Overview
     10.2 Competitive Scenario
             10.2.1 Product Launches
             10.2.2 Mergers and Acquisitions
             10.2.3 Expansions
     10.3 Competitive Leadership Mapping (Overall Market) (2018)
             10.3.1 Visionary Leaders
             10.3.2 Innovators
             10.3.3 Dynamic Differentiators
             10.3.4 Emerging Companies
     10.4 Competitive Leadership Mapping (Start-Up) (2018)
             10.4.1 Progressive Companies
             10.4.2 Starting Blocks
             10.4.3 Dynamic Companies
             10.4.4 Responsive Companies

11 Company Profiles (Page No. - 202)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     11.1 Royal DSM
     11.2 BASF SE
     11.3 Corbion
     11.4 Covestro AG
     11.5 Carpenter Technology Corporation
     11.6 Evonik Industries
     11.7 Berkeley Advanced Biomaterials, Inc.
     11.8 Cam Bioceramics B.V.
     11.9 Celanese Corporation
     11.10 CoorsTek Inc.
     11.11 CeramTec GmbH
     11.12 GELITA AG

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 226)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Available Customizations
     12.4 Related Reports
     12.5 Author Details


List of Tables (168 Tables)

Table 1 Important Properties of Biomaterials, By Application
Table 2 Market, By Type, 2017–2024 (USD Billion)
Table 3 Metallic Biomaterials: Market, By Type, 2017–2024 (USD Billion)
Table 4 Metallic Biomaterials: Market, By Region, 2017–2024 (USD Billion)
Table 5 Stainless Steel Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 6 Titanium & Titanium Alloy Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 7 Cobalt-Chrome Alloy Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 8 Gold Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 9 Silver Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 10 Magnesium Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 11 Applications of Synthetic Polymers
Table 12 Polymeric Biomaterials: Market, By Type, 2017–2024 (USD Billion)
Table 13 Polymeric Biomaterials: Market, By Region, 2017–2024 (USD Billion)
Table 14 Polymethylmethacrylate Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 15 Polyethylene Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 16 Polyester Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 17 Polyvinylchloride Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 18 Silicone Rubber Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 19 Nylon Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 20 Polyetheretherketone Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 21 Other Polymeric Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 22 Ceramic Biomaterials: Market, By Type, 2017–2024 (USD Billion)
Table 23 Ceramic Biomaterials: Market, By Region, 2017–2024 (USD Billion)
Table 24 Calcium Phosphate Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 25 Zirconia Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 26 Aluminum Oxide Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 27 Calcium Sulfate Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 28 Carbon Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 29 Glass Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 30 Applications of Natural Biomaterials
Table 31 Natural Biomaterials: Market, By Type, 2017–2024 (USD Billion)
Table 32 Natural Biomaterials: Market, By Region, 2017–2024 (USD Billion)
Table 33 Hyaluronic Acid Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 34 Collagen Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 35 Gelatin Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 36 Fibrin Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 37 Cellulose Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 38 Chitin Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 39 Alginate Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 40 Silk Biomaterials: Market, By Region, 2017–2024 (USD Million)
Table 41 Market, By Application, 2017–2024 (USD Billion)
Table 42 Market for Cardiovascular Applications, By Product, 2017–2024 (USD Billion)
Table 43 Market for Cardiovascular Applications, By Region, 2017–2024 (USD Billion)
Table 44 Market for Catheters, By Region, 2017–2024 (USD Billion)
Table 45 Market for Stents, By Region, 2017–2024 (USD Billion)
Table 46 Market for Implantable Cardiac Defibrillators, By Region, 2017–2024 (USD Billion)
Table 47 Market for Pacemakers, By Region, 2017–2024(USD Billion)
Table 48 Market for Sensors, By Region, 2017–2024 (USD Billion)
Table 49 Biomaterials Used for Different Valve Components
Table 50 Market for Heart Valves, By Region, 2017–2024 (USD Billion)
Table 51 Market for Vascular Grafts, By Region, 2017–2024 (USD Billion)
Table 52 Market for Guidewires, By Region, 2017–2024(USD Billion)
Table 53 Market for Other Cardiovascular Applications, By Region, 2017–2024 (USD Billion)
Table 54 Market for Orthopedic Applications, By Type, 2017–2024 (USD Billion)
Table 55 Market for Orthopedic Applications, By Region, 2017–2024 (USD Billion)
Table 56 Joint Replacement Biomaterials Market, By Type, 2017–2024 (USD Billion)
Table 57 Joint Replacement Market, By Region, 2017–2024 (USD Billion)
Table 58 Knee Replacement Market, By Region, 2017–2024 (USD Million)
Table 59 Hip Replacement Market, By Region, 2017–2024 (USD Million)
Table 60 Shoulder Replacement Market, By Region, 2017–2024 (USD Million)
Table 61 Other Joint Replacement Market, By Region, 2017–2024 (USD Million)
Table 62 Viscosupplementation Market, By Region, 2017–2024 (USD Million)
Table 63 Bioresorbable Market, By Product, 2017–2024 (USD Billion)
Table 64 Bioresorbable Market, By Region, 2017–2024 (USD Billion)
Table 65 Market for Suture Anchors, By Region, 2017–2024(USD Million)
Table 66 Market for Interference Screws, By Region, 2017–2024 (USD Million)
Table 67 Market for Meniscal Repair Tacks, By Region, 2017–2024(USD Million)
Table 68 Market for Meshes, By Region, 2017–2024(USD Million)
Table 69 Market for Spine Surgeries, By Type, 2017–2024 (USD Billion)
Table 70 Market for Spine Surgeries, By Region, 2017–2024 (USD Billion)
Table 71 Market for Spinal Fusion Surgeries, By Region, 2017–2024 (USD Million)
Table 72 Market for Minimally Invasive Fusion Surgeries, By Region, 2017–2024 (USD Million)
Table 73 Market for Motion Preservation & Dynamic Stabilization Surgeries, By Product, 2017–2024 (USD Million)
Table 74 Market for Motion Preservation & Dynamic Stabilization Surgeries, By Region, 2017–2024 (USD Million)
Table 75 Market for Pedicle-Based Rod Systems, By Region, 2017–2024 (USD Million)
Table 76 Market for Interspinous Spacers, By Region, 2017–2024 (USD Million)
Table 77 Market for Artificial Discs, By Region, 2017–2024 (USD Million)
Table 78 Market for Fracture Fixation Devices, By Type, 2017–2024 (USD Billion)
Table 79 Market for Fracture Fixation Devices, By Region, 2017–2024 (USD Billion)
Table 80 Market for Bone Plates, By Region, 2017–2024 (USD Million)
Table 81 Biomaterials: Market for Screws, By Region, 2017–2024 (USD Million)
Table 82 Biomaterials: Market for Pins, By Region, 2017–2024 (USD Million)
Table 83 Biomaterials: Market for Rods, By Region, 2017–2024 (USD Million)
Table 84 Biomaterials: Market for Wires, By Region, 2017–2024 (USD Million)
Table 85 Biomaterials: Market for Synthetic Bone Grafts, By Region, 2017–2024 (USD Million)
Table 86 Biomaterials: Market for Ophthalmology Applications, By Type, 2017–2024 (USD Billion)
Table 87 Biomaterials: Market for Ophthalmology Applications, By Region, 2017–2024 (USD Billion)
Table 88 Biomaterials: Market for Contact Lenses, By Region, 2017–2024 (USD Billion)
Table 89 Biomaterials: Market for Intraocular Lenses, By Region, 2017–2024 (USD Million)
Table 90 Biomaterials: Market for Functional Replacement of Ocular Tissues, By Region, 2017–2024 (USD Million)
Table 91 Biomaterials: Market for Synthetic Corneas, By Region, 2017–2024 (USD Million)
Table 92 Biomaterials: Market for Other Ophthalmology Applications, By Region, 2017–2024 (USD Million)
Table 93 Biomaterials: Market for Dental Applications, By Product, 2017–2024 (USD Billion)
Table 94 Biomaterials: Market for Dental Applications, By Region, 2017–2024 (USD Billion)
Table 95 Percentage of Individuals With Untreated Dental Caries in the US (2016)
Table 96 Market for Dental Implants, By Region, 2017–2024 (USD Billion)
Table 97 Market for Dental Bone Grafts & Substitutes, By Region, 2017–2024 (USD Million)
Table 98 Market for Dental Membranes, By Region, 2017–2024 (USD Million)
Table 99 Market for Tissue Regeneration, By Region, 2017–2024 (USD Million)
Table 100 Market for Plastic Surgery, By Application, 2017–2024 (USD Billion)
Table 101 Market for Plastic Surgery, By Region, 2017–2024 (USD Billion)
Table 102 Market for Soft-Tissue Fillers, By Region, 2017–2024 (USD Million)
Table 103 Market for Craniofacial Surgery, By Region, 2017–2024 (USD Billion)
Table 104 Market for Wound Healing Applications, By Product, 2017–2024 (USD Billion)
Table 105 Market for Wound Healing Applications, By Region, 2017–2024 (USD Billion)
Table 106 Market for Wound Closure Devices, By Product, 2017–2024 (USD Million)
Table 107 Market for Wound Closure Devices, By Region, 2017–2024 (USD Million)
Table 108 Market for Sutures, By Region, 2017–2024 (USD Million)
Table 109 Market for Staples, By Region, 2017–2024 (USD Million)
Table 110 Market for Surgical Hemostats, By Region, 2017–2024 (USD Million)
Table 111 Market for Internal Tissue Sealants, By Region, 2017–2024 (USD Million)
Table 112 Market for Adhesion Barriers, By Region, 2017–2024 (USD Million)
Table 113 Market for Hernia Meshes, By Region, 2017–2024 (USD Million)
Table 114 Tissue Engineering Biomaterials Market, By Application, 2017–2024 (USD Billion)
Table 115 Tissue Engineering Market, By Region, 2017–2024 (USD Billion)
Table 116 Tissue Engineering Market for Scaffolds for Regenerative Medicine, By Region, 2017–2024 (USD Million)
Table 117 Tissue Engineering Market for Nanomaterials for Biosensing, By Region, 2017–2024 (USD Million)
Table 118 Tissue Engineering Market for Tailoring of Inorganic Nanoparticles, By Region, 2017–2024 (USD Million)
Table 119 Market for Neurological/Cns Applications, By Product, 2017–2024 (USD Million)
Table 120 Market for Neurological/Cns Applications, By Region, 2017–2024 (USD Million)
Table 121 Market for Shunting Systems, By Region, 2017–2024 (USD Million)
Table 122 Market for Cortical Neural Prosthetics, By Region, 2017–2024 (USD Million)
Table 123 Market for Hydrogel Scaffolds for Cns Repair, By Region, 2017–2024 (USD Million)
Table 124 Market for Neural Stem Cell Encapsulation, By Region, 2017–2024 (USD Million)
Table 125 Other Biomaterial Applications Market, By Type, 2017–2024 (USD Million)
Table 126 Other Biomaterial Applications Market, By Region, 2017–2024 (USD Million)
Table 127 Market for Drug Delivery Systems, By Region, 2017–2024 (USD Million)
Table 128 Market for Gastrointestinal Applications, By Region, 2017–2024 (USD Million)
Table 129 Market for Bariatric Surgery, By Region, 2017–2024 (USD Million)
Table 130 Market for Urinary Applications, By Region, 2017–2024 (USD Million)
Table 131 Market, By Region, 2017–2024 (USD Billion)
Table 132 North America: Market, By Country, 2017–2024 (USD Billion)
Table 133 North America: Market, By Type, 2017–2024 (USD Billion)
Table 134 North America: Market, By Application, 2017–2024 (USD Billion)
Table 135 US: Market, By Type, 2017–2024 (USD Billion)
Table 136 US: Market, By Application, 2017–2024 (USD Billion)
Table 137 Canada: Market, By Type, 2017–2024 (USD Billion)
Table 138 Canada: Market, By Application, 2017–2024 (USD Million)
Table 139 Europe: Market, By Country, 2017–2024 (USD Billion)
Table 140 Europe: Market, By Type, 2017–2024 (USD Billion)
Table 141 Europe: Market, By Application, 2017–2024 (USD Billion)
Table 142 Germany: Market, By Type, 2017–2024 (USD Billion)
Table 143 Germany: Market, By Application, 2017–2024 (USD Billion)
Table 144 UK: Market, By Type, 2017–2024 (USD Billion)
Table 145 UK: Market, By Application, 2017–2024 (USD Billion)
Table 146 France: Market, By Type, 2017–2024 (USD Billion)
Table 147 France: Market, By Application, 2017–2024 (USD Billion)
Table 148 Spain: Market, By Type, 2017–2024 (USD Billion)
Table 149 Spain: Market, By Application, 2017–2024 (USD Million)
Table 150 RoE: Market, By Type, 2017–2024 (USD Billion)
Table 151 RoE: Market, By Application, 2017–2024 (USD Million)
Table 152 APAC: Market, By Country/Region, 2017–2024 (USD Billion)
Table 153 APAC: Market, By Type, 2017–2024 (USD Billion)
Table 154 APAC: Market, By Application, 2017–2024 (USD Billion)
Table 155 Japan: Market, By Type, 2017–2024 (USD Billion)
Table 156 Japan: Market, By Application, 2017–2024 (USD Billion)
Table 157 China: Market, By Type, 2017–2024 (USD Billion)
Table 158 China: Market, By Application, 2017–2024 (USD Billion)
Table 159 India: Market, By Type, 2017–2024 (USD Billion)
Table 160 India: Market, By Application, 2017–2024 (USD Million)
Table 161 RoAPAC: Market, By Type, 2017–2024 (USD Billion)
Table 162 RoAPAC: Market, By Application, 2017–2024 (USD Million)
Table 163 RoW: Market, By Type, 2017–2024 (USD Billion)
Table 164 RoW: Market, By Application, 2017–2024 (USD Billion)
Table 165 Partnerships, Agreements, and Collaborations, By Companies (2015–2019)
Table 166 Product Launches By Companies (2015–2019)
Table 167 Merger and Acquisitions By Companies (2015–2018)
Table 168 Expansions By Companies (2015–2019)


List of Figures (60 Figures)

Figure 1 Global Market Segmentation
Figure 2 Research Methodology: Market
Figure 3 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Market, By Type, 2019 vs 2024 (USD Billion)
Figure 8 Metallic Biomaterials Market, By Type, 2019 vs 2024 (USD Billion)
Figure 9 Ceramic Biomaterials Market, By Type, 2019 vs 2024 (USD Billion)
Figure 10 Polymeric Biomaterials Market, By Type, 2019 vs 2024 (USD Billion)
Figure 11 Natural Biomaterials Market, By Type, 2019 vs 2024 (USD Billion)
Figure 12 Plastic Surgery Segment to Grow at the Highest CAGR During the Forecast Period
Figure 13 North America Accounted for the Largest Share of the Market
Figure 14 Increasing Demand for Implantable Devices to Drive the Growth of the Market
Figure 15 Metallic Biomaterials to Dominate the North American Market During the Forecast Period
Figure 16 Asia Pacific to Grow at the Highest CAGR During the Forecast Period
Figure 17 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 US: Regulatory Approval Process
Figure 19 Regulatory Approval Timeline in the US
Figure 20 Canada: Regulatory Approval Process
Figure 21 Regulatory Approval Timeline in Canada
Figure 22 Europe: Regulatory Approval Process
Figure 23 Regulatory Approval Timeline in Europe
Figure 24 Japan: Regulatory Approval Process
Figure 25 Regulatory Approval Timeline in Japan
Figure 26 China: Regulatory Approval Process
Figure 27 Regulatory Approval Timeline in China
Figure 28 India: Regulatory Approval Process
Figure 29 Australia: Regulatory Approval Process
Figure 30 Regulatory Approval Timeline in Australia
Figure 31 Polymeric Biomaterials to Grow at the Highest CAGR During the Forecast Period
Figure 32 Titanium and Titanium Alloys Segment to Grow at the Highest CAGR During the Forecast Period
Figure 33 Pmma Segment to Grow at the Highest CAGR During the Forecast Period
Figure 34 Ceramic Biomaterials Market, By Type, 2017 vs 2024
Figure 35 Hyaluronic Acid Segment to Grow at the Highest CAGR During the Forecast Period
Figure 36 Plastic Surgery Segment to Register the Highest CAGR During the Forecast Period
Figure 37 Stents Segment to Register the Highest CAGR During the Forecast Period
Figure 38 Joint Replacement to Dominate the Orthopedic Biomaterials Market During the Forecast Period
Figure 39 Contact Lenses Segment to Dominate the Market for Ophthalmology Applications During the Forecast Period
Figure 40 Dental Implants Segment to Witness the Highest Growth in the Dental Market During the Forecast Period
Figure 41 Soft-Tissue Fillers Segment Will Continue to Dominate the Market for Plastic Surgery in 2024
Figure 42 Internal Tissue Sealants Segment to Register the Highest CAGR During the Forecast Period
Figure 43 Scaffolds for Regenerative Medicine Segment to Dominate the Tissue Engineering Market in 2018
Figure 44 Cortical Neural Prosthetics Segment to Register the Highest CAGR During the Forecast Period
Figure 45 Market, By Region, 2019 vs 2024 (USD Billion)
Figure 46 North America: Market Snapshot
Figure 47 Europe: Market Snapshot
Figure 48 Asia Pacific: Market Snapshot
Figure 49 RoW: Market Snapshot
Figure 50 Key Growth Strategies Adopted By Market Players
Figure 51 Competitive Leadership Mapping: Market
Figure 52 Competitive Leadership Mapping: Market
Figure 53 Royal DSM: Company Snapshot
Figure 54 BASF: Company Snapshot
Figure 55 Corbion: Company Snapshot
Figure 56 Covestro: Company Snapshot
Figure 57 Carpenter Technology: Company Snapshot
Figure 58 Evonik Industries: Company Snapshot
Figure 59 Celanese Corporation: Company Snapshot
Figure 60 CeramTec: Company Snapshot

To get more details on this report, Request FREE Sample

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the market. The primary sources from the demand side included industry experts, such as researchers and scientists, and industry experts from medical devices companies. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

Biomaterials Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by type, application, end user, and region).

Data Triangulation

After arriving at the market size, the market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments.

Objectives of the Study

  • To define, describe, segment, and forecast the market by type, application, and region.
  • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market in four main regions along with their respective key countries (North America, Europe, the Asia Pacific, and the Rest of the World)
  • To profile key players in the market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as product launches, expansions, and R&D activities of the leading players in the market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • A further breakdown of the Rest of Asia Pacific market into South Korea, New Zealand, and other South East Asian countries
  • A further breakdown of the European market into Italy, Belgium, Netherlands, Sweden, and the Rest of Europe.
Report Code
BT 1556
Published ON
Jun, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Biomaterials Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home